GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » Valuation Rank

Advanced Oncotherapy (LSE:AVO) Valuation Rank


View and export this data going back to 2006. Start your Free Trial

What is Advanced Oncotherapy Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Advanced Oncotherapy Valuation Rank Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Oncotherapy (LSE:AVO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » Valuation Rank
Comparable Companies
LSE:SUN LSE:MHC LSE:RUA LSE:DEMG LSE:POLX LSE:IHC LSE:IUG LSE:BELL ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH ALGN STE XAMS:PHIA XSWX:SOON
Traded in Other Exchanges
N/A
Address
4 Tenterden Street, Third Floor, London, GBR, W1S 1TE
Website
https://www.avoplc.com
Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.